Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 2 Medications Archives
Print | Email | Share | Comments (0)

Many Patients Given Metformin in Hospitals Despite Contraindications


May 1, 2002

Its Use in Certain Situations Can Cause Life-Threatening Complications

Many patients who are treated with metformin (Glucophage) during hospital stays have medical conditions or undergo procedures that, when combined with metformin, put them at risk for developing lactic acidosis, a potentially life-threatening condition caused by a build-up of lactic acid that can lead to organ damage.

Amy T. Calabrese, PharmD, and colleagues from the University of Pittsburgh, writing in the February 25, 2002, issue of the Archives of Internal Medicine, evaluated the effects of metformin therapy on 204 patients who were admitted to the hospital during a six-month study period and who were given at least one dose of the drug.

In 71 admissions (27 percent), patients who had at least one absolute condition that made use of metformin inadvisable were given at least one dose of the drug during admission. In 29 of those admissions, treatment with metformin was continued, despite the risk. The most common contraindication, evidence of kidney dysfunction, was present or developed during admission in 32 of the patients. However, metformin therapy was stopped in only eight of those cases.

In 97 admissions, metformin was given even though the patients were undergoing studies involving intravenous contrast dyes, which is one of the most common conditions that should argue against using metformin, the researchers note.

"Many patients are treated with metformin despite having clinical conditions that place them at risk for developing lactic acidosis," write the researchers. To avoid this problem, those prescribing the drug need to "develop a better understanding of the prescribing guidelines."


Categories: Hospital Care, Metformin, Type 2 Medications



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - May 1, 2002

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.